AI assistant
Sending…
CStone Pharmaceuticals — Director's Dealing 2022
Jun 17, 2022
50715_rns_2022-06-17_75630153-9cbe-42d0-9f90-635839de1997.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [173 x 58] intentionally omitted <==
Public Disclosure Form
17 June 2022
Possible offer
Disclosure of dealings in the shares of Yankuang Energy Group Company Limited
The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:
| Party | Date | Descriptionof relevantsecurities | Nature of dealings | Purchase/ Sale | Totalnumber ofsharesinvolved | Total amountpaid / received | Highest (H)prices paid/ received | Lowest (L)prices paid/ received |
|---|---|---|---|---|---|---|---|---|
| CICC PuchengInvestment Co.,Ltd. | 16 June2022 | Other typesof securities(e.g. equityswaps) | Closing / flattening / unwinding ofproprietary positions arising fromunsolicited client-driven dealings. Iconfirm this was done no later thanthe close of the morning tradingsession on the trading day followingthe orginating client-driven dealing | Sale | 10,000 | $263,000.0000 | $26.3000 | $26.3000 |
==> picture [71 x 43] intentionally omitted <==
Public Disclosure Form
| Other typesof securities(e.g. equityswaps) | Closing / flattening / unwinding ofproprietary positions arising fromunsolicited client-driven dealings. Iconfirm this was done no later thanthe close of the morning tradingsession on the trading day followingthe orginating client-driven dealing | Purchase | 10,000 | $263,494.0500 | $26.3494 | $26.3494 |
|---|
End
Note:
CICC Pucheng Investment Co., Ltd. is an exempt principal trader connected with the Offeror. Dealings were made for its own account.
CICC Pucheng Investment Co., Ltd. is ultimately owned by China International Capital Corporation Limited.
More from CStone Pharmaceuticals
Transaction in Own Shares
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 7
Environmental & Social Information
2026
Apr 27
Annual Report
2026
Apr 27
Share Issue/Capital Change
2026
Apr 23
Share Issue/Capital Change
2026
Apr 22
Share Issue/Capital Change
2026
Apr 22
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 20